Currently, there are 279.82M common shares owned by the public and among those 238.57M shares have been available to trade.
The company’s stock has a 5-day price change of -11.90% and 70.85% over the past three months. It has a 12-month low price of $2.61 and touched a high of $18.63 over the same period. CORZ has an average intraday trading volume of 10.55 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.86%, 12.80%, and 86.24% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Core Scientific Inc (NASDAQ: CORZ) shares accounts for 62.18% of the company’s 279.82M shares outstanding.
It has a market capitalization of $4.53B. The earnings-per-share (ttm) stands at -$5.45. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.86% over the week and 7.35% over the month.
Earnings per share for the fiscal year are expected to decrease by -508.00%, and 103.62% over the next financial year.
Looking at the support for the CORZ, a number of firms have released research notes about the stock. ROTH MKM stated their Buy rating for the stock in a research note on November 15, 2024, with the firm’s price target at $25.50. Jefferies coverage for the Core Scientific Inc (CORZ) stock in a research note released on October 28, 2024 offered a Buy rating with a price target of $19. Macquarie was of a view on September 25, 2024 that the stock is Outperform, while Canaccord Genuity gave the stock Buy rating on September 23, 2024, issuing a price target of $16. Needham on their part issued Buy rating on September 04, 2024.
